Safety of statins in dyslipidemic patients with chronic hepatitis C viral infection /
Ragab Abdelhafiez Shokr
Safety of statins in dyslipidemic patients with chronic hepatitis C viral infection / دراسة درجة امان عقار الستاتين لدى مرضى الالتهاب الكبدى الفيروسى (سي) ذوى الكولسترول المرتفع Ragab Abdelhafiez Shokr ; Supervised Hesham Salah Eldin Taha , Sameh Wadae Bakhoum - Cairo : Ragab Abdelhafiez Shokr , 2013 - 145 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology
Some studies have shown that patients with hepatitis C are at increased risk cardiovascular disease based on increased carotid intima- media thickness⁴ . These increases in markers of early atherosclerosis in chronic hepatitis C may make 3- hydroxy -3- methylglutary 1 coenzyme A reductase inhibitors (statins) of a particular benefit in this patient population
Dyslipidemic Hepatitis C Statins
Safety of statins in dyslipidemic patients with chronic hepatitis C viral infection / دراسة درجة امان عقار الستاتين لدى مرضى الالتهاب الكبدى الفيروسى (سي) ذوى الكولسترول المرتفع Ragab Abdelhafiez Shokr ; Supervised Hesham Salah Eldin Taha , Sameh Wadae Bakhoum - Cairo : Ragab Abdelhafiez Shokr , 2013 - 145 P. : charts , facsimiles ; 25cm
Thesis (M.Sc.) - Cairo University - Faculty of Medicine - Department of Cardiology
Some studies have shown that patients with hepatitis C are at increased risk cardiovascular disease based on increased carotid intima- media thickness⁴ . These increases in markers of early atherosclerosis in chronic hepatitis C may make 3- hydroxy -3- methylglutary 1 coenzyme A reductase inhibitors (statins) of a particular benefit in this patient population
Dyslipidemic Hepatitis C Statins